Ganeden Biotech, Inc. Report issue

For profit Phase 4
Founded: Ohio IL United States (1997)
Status: Acquired by Kerry (2017)

Organization Overview

First Clinical Trial
2008
NCT00881322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

ganedenbc30 (2 trials)

Drugs in Other Trials (2)

b. coagulans (1 trial)

cellulase (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

HIV Infections (Phase 2)

Irritable Bowel Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3